Arch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering and Quality Systems and Peter LaCrosse as Chief of Staff
01 avr. 2014 08h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Apr 1, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke, PhD Presents at Two Scientific Meetings in March
26 mars 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Mar 26, 2014) - Rutledge Ellis-Behnke, PhD, co-founder and inventing scientist at Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or "the Company"), a life sciences...
Arch Therapeutics to Present at The Wall Street Analyst Forum Institutional Investor Conference
26 févr. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Feb 26, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Secures $2.85 Million Private Placement
10 févr. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Feb 10, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Announces $2.85 Million Private Placement
31 janv. 2014 06h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 31, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Presents 2014 Milestones During Live Webcast
22 janv. 2014 11h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 22, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics to Present Status Update and Milestone Overview at Noble Financial Capital Markets' Tenth Annual Equity Conference
14 janv. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 14, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics to Webcast Live From the Biotech Showcase Investor Conference
08 janv. 2014 09h00 HE
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 8, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of AC5™, a novel product aimed at...
Blood Banking And Blood Products - Global Strategic Business Report 2012-2018
20 nov. 2013 09h48 HE
|
Research and Markets
Dublin, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/tlzw4c/blood_banking_and)
has announced the addition of the
"Blood Banking And Blood...
Blood Processing Supplies And Equipment
15 nov. 2013 10h32 HE
|
Research and Markets
Dublin, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Blood Processing Supplies And Equipment - Global
Strategic Business Report - 2012
Research and Markets...